Targeted Delivery Of A Novel Synthetic Curcumin Analog, EF24 To Glioblastoma And
Targeted Delivery Of A Novel Synthetic Curcumin Analog, EF24 To Glioblastoma And | |
|---|---|
| Sponsor(s) | National Institute of Health |
| Program Type | R21 |
| Principal Investigator(s) | Mamoru Shoji, MD |
| Dates | 3/01/2011 - 2/28/2013 |
